Global Oncolytic Virus Immunotherapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 14-Sep-2018
No. of pages: 123

Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).

Scope of the Report:

This report studies the Oncolytic Virus Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncolytic Virus Immunotherapy market by product type and applications/end industries.

North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.

The global Oncolytic Virus Immunotherapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncolytic Virus Immunotherapy.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

-Merck

-Amgen

-TILT Biotherapeutics

-Oncorus

-Sorrento Therapeutics

-Shanghai Sunway Biotech

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

-Engineering Oncolytic Viruses

-Wild-Type Oncolytic Viruses

Market Segment by Applications, can be divided into

-Hospitals

-Clinics

-Ambulatory Surgical Centers

Global Oncolytic Virus Immunotherapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents
1 Oncolytic Virus Immunotherapy Market Overview
1.1 Product Overview and Scope of Oncolytic Virus Immunotherapy
1.2 Classification of Oncolytic Virus Immunotherapy by Types
1.2.1 Global Oncolytic Virus Immunotherapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Types in 2017
1.2.3 Engineering Oncolytic Viruses
1.2.4 Wild-Type Oncolytic Viruses
1.3 Global Oncolytic Virus Immunotherapy Market by Application
1.3.1 Global Oncolytic Virus Immunotherapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Oncolytic Virus Immunotherapy Market by Regions
1.4.1 Global Oncolytic Virus Immunotherapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
1.5 Global Market Size of Oncolytic Virus Immunotherapy (2013-2023)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Oncolytic Virus Immunotherapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Oncolytic Virus Immunotherapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 TILT Biotherapeutics
2.3.1 Business Overview
2.3.2 Oncolytic Virus Immunotherapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Oncorus
2.4.1 Business Overview
2.4.2 Oncolytic Virus Immunotherapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sorrento Therapeutics
2.5.1 Business Overview
2.5.2 Oncolytic Virus Immunotherapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Shanghai Sunway Biotech
2.6.1 Business Overview
2.6.2 Oncolytic Virus Immunotherapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oncolytic Virus Immunotherapy Market Competition, by Players
3.1 Global Oncolytic Virus Immunotherapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncolytic Virus Immunotherapy Players Market Share
3.2.2 Top 10 Oncolytic Virus Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Global Oncolytic Virus Immunotherapy Market Size by Regions
4.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Regions
4.2 North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.3 Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.5 South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
5 North America Oncolytic Virus Immunotherapy Revenue by Countries
5.1 North America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
5.2 USA Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
5.3 Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6 Europe Oncolytic Virus Immunotherapy Revenue by Countries
6.1 Europe Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
6.2 Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.3 UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.4 France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.5 Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.6 Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries
7.1 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
7.2 China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.3 Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.4 Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.5 India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
8 South America Oncolytic Virus Immunotherapy Revenue by Countries
8.1 South America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
8.2 Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Oncolytic Virus Immunotherapy by Countries
9.1 Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.3 UAE Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
10 Global Oncolytic Virus Immunotherapy Market Segment by Type
10.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2013-2018)
10.2 Global Oncolytic Virus Immunotherapy Market Forecast by Type (2018-2023)
10.3 Engineering Oncolytic Viruses Revenue Growth Rate (2013-2023)
10.4 Wild-Type Oncolytic Viruses Revenue Growth Rate (2013-2023)
11 Global Oncolytic Virus Immunotherapy Market Segment by Application
11.1 Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2013-2018)
11.2 Oncolytic Virus Immunotherapy Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 Global Oncolytic Virus Immunotherapy Market Size Forecast (2018-2023)
12.1 Global Oncolytic Virus Immunotherapy Market Size Forecast (2018-2023)
12.2 Global Oncolytic Virus Immunotherapy Market Forecast by Regions (2018-2023)
12.3 North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.4 Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.6 South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Oncolytic Virus Immunotherapy Picture
Table Product Specifications of Oncolytic Virus Immunotherapy
Table Global Oncolytic Virus Immunotherapy and Revenue (Million USD) Market Split by Product Type
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Types in 2017
Figure Engineering Oncolytic Viruses Picture
Figure Wild-Type Oncolytic Viruses Picture
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Application (2013-2023)
Figure Oncolytic Virus Immunotherapy Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Ambulatory Surgical Centers Picture
Table Global Market Oncolytic Virus Immunotherapy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Oncolytic Virus Immunotherapy Type and Applications
Table Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Oncolytic Virus Immunotherapy Type and Applications
Table Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table TILT Biotherapeutics Oncolytic Virus Immunotherapy Type and Applications
Table TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Oncorus Basic Information, Manufacturing Base and Competitors
Table Oncorus Oncolytic Virus Immunotherapy Type and Applications
Table Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Oncolytic Virus Immunotherapy Type and Applications
Table Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Type and Applications
Table Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Players (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Players (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Players in 2016
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Players in 2017
Figure Global Top 5 Players Oncolytic Virus Immunotherapy Revenue Market Share in 2017
Figure Global Top 10 Players Oncolytic Virus Immunotherapy Revenue Market Share in 2017
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Regions (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions in 2017
Figure North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table North America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
Table North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure USA Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Europe Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table South America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
Table South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Argentina Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Colombia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure UAE Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Nigeria Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Type (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Type (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Type (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Type in 2017
Table Global Oncolytic Virus Immunotherapy Revenue Forecast by Type (2018-2023)
Figure Global Oncolytic Virus Immunotherapy Market Share Forecast by Type (2018-2023)
Figure Global Engineering Oncolytic Viruses Revenue Growth Rate (2013-2018)
Figure Global Wild-Type Oncolytic Viruses Revenue Growth Rate (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue by Application (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Application (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Application (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Application in 2017
Table Global Oncolytic Virus Immunotherapy Revenue Forecast by Application (2018-2023)
Figure Global Oncolytic Virus Immunotherapy Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
  • NPWT Devices Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Feb-2019        Price: US 3000 Onwards        Pages: 144
    NPWT Devices Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global NPWT Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the NPWT Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese NPWT Devices market coverin......
  • Newborn Screening Instruments Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Feb-2019        Price: US 3000 Onwards        Pages: 144
    Newborn Screening Instruments Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Newborn Screening Instruments industry with a focus on the Chinese market. The report provides key statistics on the market status of the Newborn Screening Instruments manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-......
  • New Baby Monitoring System Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Feb-2019        Price: US 3000 Onwards        Pages: 148
    New Baby Monitoring System Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global New Baby Monitoring System industry with a focus on the Chinese market. The report provides key statistics on the market status of the New Baby Monitoring System manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 glob......
  • Global Pit & Fissure Sealants Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 109
    Pit & Fissure Sealant is a fluoride releasing light curing sealant for primary or permanent teeth. It is used in preventive dentistry where it has been clinically proven that sealants are effective in the prevention of caries. The fluoride that is released offers an additional protection against caries and its ideal viscosity allows it to penetrate into the deepest pits and fissures to ensure total sealing. The global Pit & Fissure Sealants market is valued at xx million US$ in 20......
  • Global Core Biopsy Needles Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 96
    A core needle biopsy is a medical test to remove a piece of tissue from a lesion or mass. Core Biopsy Needle is the needles used for core needle biopsy. The global Core Biopsy Needles market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Core Biopsy Needles volume and value at global level, regional level and company level. From a global perspective, this report re......
  • Global Retractable Safety Syringes Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 105
    Safety syringes are syringes developed with a safety mechanism to prevent needle stick and other injuries. The needle on a safety syringe can be detachable or permanently attached. The emphasis on preventing the re-use of syringes by safety bodies and governments has raised the demand for safety syringes. Syringes with retractable needles and syringes with protective shields are safety syringes widely used in hospitals. Retractable needle - the needle (usually fused to the syringe) is spring-loa......
  • Global Spine Surgical Devices Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 104
    Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products. Non-fusion products are used during spine surgery, which are implanted to treat spine conditions. This also allows the patient to retain its movement and flexibility. The non-fusion products are becoming the treatment of choice, especially for the younger, more active patient. Increase in number of spine surgeries, rise in use of bone grafts ......
  • Global Superabsorbent Dressings Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 101
    Superabsorbent Dressings are multilayer wound protections, comprised of a semi or non-adhesive layers and extreme adsorptive layers of fibers. They are used as in management of severe exudating wounds such as ulcerating cancer wounds, dehiscence wounds, and exuding ulcers. The global Superabsorbent Dressings market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Sup......
  • Global Therapeutic Stents Market Research Report 2019
    Published: 19-Feb-2019        Price: US 2900 Onwards        Pages: 106
    Therapeutic stent is a metallic or a polymer tube implanted into the lumen of blood vessels or ducts to keep the passage open. A stent implant is commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to facilitate the passage of food & beverages in patients suffering from esophageal cancer. The global Therapeutic Stents market is valued at xx million US$ in 2018 is expected to reach xx million US$......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs